Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome.
CONCLUSIONS In patients with diabetes and the co-morbidity of ACS, a high serum level of calprotectin was associated with a significantly increased risk for MACE following PCI.
PMID: 31834876 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Angioplasty | Biomedical Science | Cardiology | Cardiovascular | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Percutaneous Coronary Intervention | Research | Science | Study